Maarten van Lemmen

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
Targeting the Carotid Body Function With Big-K+-Channel Blocker ENA-001 in Opioid-Induced Respiratory Depression: A Scoping Review.

|Feb 05, 2026
Intranasal Naloxone Reversal of Opioid-induced Respiratory Depression in Opioid-naive Individuals and Self-reported Daily Opioid Users.

Maarten A van Lemmen, Jeffry Florian, Zhihua Li

|Jul 11, 2025
Recovery of the Acute Hypoxic Ventilatory Response after Reversal of a Minimal Neuromuscular Block: A Randomized Controlled Trial in Healthy, Nonobese Volunteers.

Merel A J Snoek, Maarten A van Lemmen, Rutger van der Schrier

|May 19, 2025
A comparison of intramuscular (Zimhi) and intranasal naloxone (Narcan) in reversal of fentanyl-induced apnea: a randomized, crossover, open-label trial.

Maarten A van Lemmen, Monique van Velzen, Elise Y Sarton

Pageof 1

Frequent Collaborators

3 joint publications

Albert Dahan

3 joint publications

Rutger van der Schrier

2 joint publications

Monique van Velzen

1 joint publications

Merel A J Snoek